1. Home
  2. IPSC vs TPCS Comparison

IPSC vs TPCS Comparison

Compare IPSC & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • TPCS
  • Stock Information
  • Founded
  • IPSC 2019
  • TPCS 1956
  • Country
  • IPSC United States
  • TPCS United States
  • Employees
  • IPSC N/A
  • TPCS N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • TPCS Metal Fabrications
  • Sector
  • IPSC Health Care
  • TPCS Industrials
  • Exchange
  • IPSC Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • IPSC 49.1M
  • TPCS 51.4M
  • IPO Year
  • IPSC 2021
  • TPCS N/A
  • Fundamental
  • Price
  • IPSC $0.57
  • TPCS N/A
  • Analyst Decision
  • IPSC Strong Buy
  • TPCS
  • Analyst Count
  • IPSC 5
  • TPCS 0
  • Target Price
  • IPSC $3.33
  • TPCS N/A
  • AVG Volume (30 Days)
  • IPSC 730.7K
  • TPCS 30.8K
  • Earning Date
  • IPSC 11-04-2025
  • TPCS 08-21-2025
  • Dividend Yield
  • IPSC N/A
  • TPCS N/A
  • EPS Growth
  • IPSC N/A
  • TPCS N/A
  • EPS
  • IPSC N/A
  • TPCS N/A
  • Revenue
  • IPSC $114,128,000.00
  • TPCS $33,424,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • TPCS N/A
  • Revenue Next Year
  • IPSC N/A
  • TPCS N/A
  • P/E Ratio
  • IPSC N/A
  • TPCS N/A
  • Revenue Growth
  • IPSC 5491.77
  • TPCS 3.78
  • 52 Week Low
  • IPSC $0.34
  • TPCS $2.05
  • 52 Week High
  • IPSC $1.83
  • TPCS $6.25
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 60.85
  • TPCS 45.10
  • Support Level
  • IPSC $0.52
  • TPCS $5.32
  • Resistance Level
  • IPSC $0.62
  • TPCS $5.64
  • Average True Range (ATR)
  • IPSC 0.03
  • TPCS 0.25
  • MACD
  • IPSC 0.01
  • TPCS -0.05
  • Stochastic Oscillator
  • IPSC 64.94
  • TPCS 6.56

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: